Abstract
Introduction: miRs, small molecules with wide impact miRs are a family of short non-coding transcripts involved in the regulation of at least a third of all translated genes
. They are expressed as primary transcripts, which are subsequently processed by the Drosha RNase, thus generating the hairpinshaped precursor miRs (pre-miRs). Pre-miRs are then cleaved by another RNase III (Dicer) , which leads to the formation of mature duplexes (19-24- [4] . The classic view of miR action was that in mammalian cells miRs act predominantly, if not exclusively, by blocking the translation of mRNA targets. However, more recently, it has become apparent that the action is more complex, with mRNA degradation being quite frequent, in a similar fashion to siRNAs [5, 6] . To further increase the intricate nature of miR action, cases of enhanced protein translation have been recently reported [7] . miRs continue to be at the centrestage of the 'non-coding RNA revolution', currently being suspected to regulate virtually all known cellular mechanisms, such as cell differentiation, proliferation, death and metabolism [8] [9] [10] [11] . An increasing number of miRs have been associated with the various steps of tumourigenesis [12] . On the one hand, specific miR expression profiles have been associated with human cancers, and in some cases correlated with clinico-pathological features [13] [14] [15] [16] [17] [18] . On the other hand, mechanistically individual miRs can function as bona fide oncogenes (such as miR-17-92 [19] , miR-10b [20] , miR-21 [21, 22] 
nucleotide long). One of the two strands is selectively transferred to the RNA-induced silencing complex (RISC), which interferes with gene expression at posttranscriptional level

,) or tumour suppressor genes (such as miR-15-16 clusters [23]).
A role for hypoxia in the regulation of miR expression
Recent studies have shed significant light into the regulation of miR expression and information is accumulating on the impact of specific stresses on the 'miR-nome'. Arguably, the best-documented cellular stress is oxygen deprivation (hypoxia), which is of relevance for a variety of diseases of major impact [24] .
Hypoxia is an essential feature of the neoplastic microenvironment. Tumours with extensive low oxygen tension tend to exhibit poor prognosis and resistance to conventional therapy [25] . Moreover, hypoxia is also a crucial pathogenic component of major cardiovascular diseases, such as myocardial infarction and stroke [26] . The 24, 26a, 26b, 27a, 30b, 93, 103, 106a, 107, 125b, 181a, 181b, 181c, 192, 195 and 213 . Of these, only miR-30b, 93 and 181b were independently confirmed by a separate study [38] . A more recent set of data identified only three miRs (miR-210, ambimiR-7105 and mmu-miR-322-3p), which showed at least 2-fold induction in response to hypoxia [33] . In non-cancer cells, miR-210 was identified as a key player of endothelial cells response to low oxygen tension [34] , and therefore this miR is emerging as a universal responder to hypoxia, with likely deep biological impact in the response to this type of stress.
Finally, according to two studies, hypoxia can also lead to miR down-regulation, including: miR-15b, 16, 19a, 20a, 20b, 29b and 197 [38, 39] . Whether these represent specific targets of HIF, or this process is simply the result of cell cycle arrest, is not known at this point.
As results from above, beyond general agreement with regards to miR-210, there has been rather limited overlap in miRs regulated by hypoxia. These discrepancies are not necessarily surprising, and could be explained by the differences in cells examined, technology employed, differences in the thresholds and time investigated, as well as oxygen concentrations [35, 36] .
In most tumours, the expression of miR-210 is significantly up-regulated compared to the corresponding non-malignant tissue [14, 16, 18, 33] . The exception, according to one study, is represented by the ovarian carcinomas that tend to lose the locus encoding for miR-210, and as consequence exhibit decreased expression of this miR [32] . More significantly than altered expression in cancers, miR-210 has been shown to correlate with a hypoxia signature score in human breast cancers and strongly associate with an adverse clinical outcome [33] . [40] [41] [42] . Recently, miR-34a joined the targets of the transcription factor (and tumour suppressor gene product) p53, and has been shown to contribute to its function [43] [44] [45] . [31, 33, 34] [34] . Moreover, the dynamic of miR-210 induction exhibits a notable difference compared to HIF, as it continues to increase beyond the peak of HIF protein level [31, 34] .
Role of HIF in the regulation of miR-210
It is not surprising that the HIF was interrogated first with regards to a role in miR regulation. At least for miR-210, HIF is clearly a critical factor for the hypoxic induction, as determined in several studies
Several issues remain to be elucidated with respect to miR-210 regulation, for example the existence of other possible mechanisms. Growth factor deprivation, osmotic stress, acidosis and oxidative stress did not elicit miR-210 increase, but additional conserved candidate transcription factor sites are present in the proximity of miR-210: Oct-C, AP2, PPAR ␥ and E2F [35, 36] . [47] [48] [49] . When more than one search program is used, the in silico predictions often exceed one hundred genes, thus posing significant challenges to the effort to identify the biologically relevant targets.
These could potentially regulate its expression as part of the hypoxia response -in the case of Oct-4, itself a hypoxia regulate gene [46] -or as part of unrelated pathways. While miR-210 was initially thought to be intergenic, a more recent study showed that it is in fact contained within the sequence of a transcript with virtually unknown function (AK123483) [33]. This transcript is also hypoxia inducible, consistent with published observations of coordinated expression of miRs and the corresponding host genes. Whether this transcript encodes for a protein or plays any biological role in the hypoxia response is not known as yet.
The ongoing search for miR-210 targets
Identification of miRs targets remains without a doubt a highly complex endeavour. An increasing number of prediction programs for target identification are currently available, such as PicTar, TargetScan and Miranda
The first clues about genes(pathways that may be targeted by miR-210 were provided by a computational analysis [50] [31, [33] [34] [35] [36] . This diversity, combined with the salient discrepancies between prediction programs, raises experimental challenges, one prediction being that manipulation of any individual target will fail to fully capture the phenotypic impact of the corresponding miR in low oxygen.
Despite the above challenges, biologically relevant miR-210 targets have started to emerge [32, 34] (Fig. 2) . One study focusing on the response of endothelial cells to hypoxia identified EphrinA3 as target of miR-210 in hypoxic conditions [34] 
Perspectives: towards clinical applications of miR-210 manipulation
The recent study by Camps et al. [33] [64] [65] [66] .
Another example of disease with a hypoxic component is preeclampsia, which is associated with accumulation of HIF-alpha proteins at placental level [67] . Consistent with its status of HIF target, miR-210 was found up-regulated in placentas from patients with preeclampsia, compared to normal pregnant women. Again, whether miR-210 contributes to the clinical manifestations of this condition is yet to be determined. 
